131 related articles for article (PubMed ID: 38352468)
1.
Li Z; Barnaby R; Nymon A; Roche C; Koeppen K; Ashare A; Hogan DA; Gerber SA; Taatjes DJ; Hampton TH; Stanton BA
bioRxiv; 2024 Feb; ():. PubMed ID: 38352468
[TBL] [Abstract][Full Text] [Related]
2.
Li Z; Barnaby R; Nymon A; Roche C; Koeppen K; Ashare A; Hogan DA; Gerber SA; Taatjes DJ; Hampton TH; Stanton BA
Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L574-L588. PubMed ID: 38440830
[TBL] [Abstract][Full Text] [Related]
3. Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles.
Koeppen K; Barnaby R; Jackson AA; Gerber SA; Hogan DA; Stanton BA
PLoS One; 2019; 14(1):e0211290. PubMed ID: 30682135
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles secreted by primary human bronchial epithelial cells reduce
Sarkar S; Barnaby R; Nymon AB; Taatjes DJ; Kelley TJ; Stanton BA
Am J Physiol Lung Cell Mol Physiol; 2024 Feb; 326(2):L164-L174. PubMed ID: 38084406
[TBL] [Abstract][Full Text] [Related]
5. Cyclodextrins reduce the ability of Pseudomonas aeruginosa outer-membrane vesicles to reduce CFTR Cl
Barnaby R; Koeppen K; Stanton BA
Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L206-L215. PubMed ID: 30358440
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa Leucine Aminopeptidase Influences Early Biofilm Composition and Structure via Vesicle-Associated Antibiofilm Activity.
Esoda CN; Kuehn MJ
mBio; 2019 Nov; 10(6):. PubMed ID: 31744920
[No Abstract] [Full Text] [Related]
7. A Novel Mechanism of Host-Pathogen Interaction through sRNA in Bacterial Outer Membrane Vesicles.
Koeppen K; Hampton TH; Jarek M; Scharfe M; Gerber SA; Mielcarz DW; Demers EG; Dolben EL; Hammond JH; Hogan DA; Stanton BA
PLoS Pathog; 2016 Jun; 12(6):e1005672. PubMed ID: 27295279
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway.
Zhao K; Deng X; He C; Yue B; Wu M
Infect Immun; 2013 Dec; 81(12):4509-18. PubMed ID: 24082079
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary inflammation induced by bacteria-free outer membrane vesicles from Pseudomonas aeruginosa.
Park KS; Lee J; Jang SC; Kim SR; Jang MH; Lötvall J; Kim YK; Gho YS
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):637-45. PubMed ID: 23713467
[TBL] [Abstract][Full Text] [Related]
10. Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice.
Zhang X; Yang F; Zou J; Wu W; Jing H; Gou Q; Li H; Gu J; Zou Q; Zhang J
Vaccine; 2018 Feb; 36(8):1047-1054. PubMed ID: 29406241
[TBL] [Abstract][Full Text] [Related]
11. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
[TBL] [Abstract][Full Text] [Related]
12. Specific Inhibition of the NLRP3 Inflammasome as an Antiinflammatory Strategy in Cystic Fibrosis.
McElvaney OJ; Zaslona Z; Becker-Flegler K; Palsson-McDermott EM; Boland F; Gunaratnam C; Gulbins E; O'Neill LA; Reeves EP; McElvaney NG
Am J Respir Crit Care Med; 2019 Dec; 200(11):1381-1391. PubMed ID: 31454256
[No Abstract] [Full Text] [Related]
13.
Cooke AC; Florez C; Dunshee EB; Lieber AD; Terry ML; Light CJ; Schertzer JW
mSphere; 2020 Nov; 5(6):. PubMed ID: 33239369
[TBL] [Abstract][Full Text] [Related]
14. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.
Wang Y; Cela E; Gagnon S; Sweezey NB
Respir Res; 2010 Nov; 11(1):166. PubMed ID: 21118573
[TBL] [Abstract][Full Text] [Related]
15. Bacterial outer membrane vesicles bound to bacteriophages modulate neutrophil responses to bacterial infection.
Pennetzdorfer N; Popescu MC; Haddock NL; Dupuy F; Kaber G; Hargil A; Johansson PK; Enejder A; Bollyky PL
Front Cell Infect Microbiol; 2023; 13():1250339. PubMed ID: 37965262
[No Abstract] [Full Text] [Related]
16. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
[TBL] [Abstract][Full Text] [Related]
17. Septin-dependent defense mechanisms against Pseudomonas aeruginosa are stalled in cystic fibrosis bronchial epithelial cells.
Brax S; Gaudin C; Calmel C; Boëlle PY; Corvol H; Ruffin M; Guillot L
Eur J Cell Biol; 2024 Apr; 103(2):151416. PubMed ID: 38636185
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa outer membrane vesicles ameliorates lung ischemia-reperfusion injury by regulating the balance of regulatory T cells and Th17 cells through Tim-3 and TLR4/NF-κB pathway.
Liu B; Ding F; Cao D; Liu J; Wang Y; Wu C
Inflamm Res; 2021 Aug; 70(8):891-902. PubMed ID: 34223915
[TBL] [Abstract][Full Text] [Related]
19. Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model.
Tappenden P; Harnan S; Uttley L; Mildred M; Carroll C; Cantrell A
Health Technol Assess; 2013 Dec; 17(56):v-xvii, 1-181. PubMed ID: 24290164
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis.
Westhölter D; Beckert H; Straßburg S; Welsner M; Sutharsan S; Taube C; Reuter S
J Cyst Fibros; 2021 Nov; 20(6):1072-1079. PubMed ID: 34030985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
